10% Owner Blavatnik Len and Affiliates Make $12.5M Open Market Purchase Following Public Offering
ZURA has more than doubled off its 52-week low of $0.97.
Summary
Blavatnik Len and related 10% owners acquired $12.5 million worth of Zura Bio Ltd. shares in an open market purchase, participating in the company's recent public offering.
Key Events · Ownership and Investor Activity · ZURA
-
Significant Insider Purchase
Blavatnik Len and affiliated entities, identified as 10% owners, purchased 2,000,000 Class A Ordinary Shares for a total value of $12,500,000.00 at a price of $6.25 per share.
-
Participation in Recent Offering
The acquisition was made on February 26, 2026, pursuant to a registered public offering by the Issuer, which was finalized on the same day, raising $134.6 million in net proceeds.
-
Increased Holdings
Following this transaction, the reporting owners' direct holdings increased to 6,552,725 shares.
Analysis · ZURA · Life Sciences
This Form 4 filing reveals a substantial $12.5 million open market purchase by Blavatnik Len and affiliated entities, who are 10% owners of Zura Bio Ltd. The purchase, made on February 26, 2026, was part of the company's recently finalized public offering, which raised $134.6 million. A significant investment of this magnitude by a major existing shareholder, especially following a capital raise, signals strong confidence in the company's future prospects. The transaction occurred while the stock is trading near its 52-week high, further underscoring the insider's conviction.
How filings like this one have moved
In the 30 days to Sep 21, 2026, 34.9% of the 999 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ZURA was trading at $6.89 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $562.6M. The 52-week trading range was $0.97 to $7.19. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.